Author Archives: Admin

Kraig Biocraft Laboratories accelerates development of new recombinant Spider Silk Fibers

ANN ARBOR, Mich., – September 18, 2018 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers announces today that it has implemented two major advancements in the development of next generation recombinant spider silk fibers. 

These advancements are the result of new equipment and recently employed protocols, at the Company’s R&D headquarters, based in Michigan.  These new approaches build on the existing protocols, but allow the Company to increase processing efficiency significantly.  The Company expects to see higher throughput as this approach should result in shorter times to generate new transgenics.  What previously took an entire day to complete can now be done in a matter of minutes.

The Company expects that, with these new methods, it will be able to drastically accelerate the pace of development for next generation recombinant spider silk fibers and technologies, but does not affect the opening of the Company’s aggressive production operations through its Vietnamese subsidiary, Prodigy Textiles.  The Company expects to provide an update on its progress at Prodigy Textiles in the near future.

 “As we continue to make significant progress commercializing and scaling production of our existing recombinant spider silk offerings, our research team, led by Dr. Trevor Kane, remains focused on the creation of the next evolution of high performance spider silk materials,” said COO, Jon Rice.  “The new processes and equipment implemented today play a key role in that work, allowing for major increases in throughput and what we expect to be faster development cycles.”

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

 

This entry was posted on by .

Kraig Biocraft Laboratories delivers ballistic shootpack panels to U.S. Army

ANN ARBOR, Mich., – August 20, 2018 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces today that it has delivered ballistic shootpack panels to the U.S. Army made from the Company’s proprietary Dragon Silk™ material.  These panels will be evaluated for effectiveness in stopping bullets, in an effort to provide our Warfighters with a lighter and more comfortable alternative to conventional protective apparel.

Dragon Silk is a genetically engineered spider silk which mimics the strength and toughness found in native spider silk, but which can be produced at large quantities through the Company’s specially developed silkworms.  These specially engineered silkworms were developed to be a direct drop-in replacement into the traditional silk production infrastructure which produces more than 150,000 metric tons of silk per year.  This approach of adapting the existing production infrastructure is the key differentiator between the Company and others working to produce spider silk materials.

Unlike traditional synthetic materials such as Ultra High Molecular Weight (UHMW) polymers or aramids, which are very stiff, spider silk is extremely flexible, making it more comfortable and providing higher mobility and movement for the wearer.  Spider silk is also biocompatible, making it ideal for skin contact applications, and biodegradable, reducing the environmental burden of the current synthetic materials

“After years of research and investment, developing this ground breaking technology, we are very excited to now see it in the hands of the U.S. Army,” stated Jon Rice, COO.  “For me, personally, and for the Company, the opportunity to help protect the brave men and women whom dedicate themselves to our protection is a great honor.”

The Company continues to develop the next generation of high performance recombinant spider silk materials under the exercised contract option period authorized in 2017 and is currently in the process of opening a production facility in Vietnam to significantly expand its production capacity of Dragon Silk and its many other recombinant spider silk offerings.

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

 

This entry was posted on by .

Kraig Biocraft Laboratories reports Farming Cooperatives break ground in Vietnam

ANN ARBOR, Mich., – July 31, 2018 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers announces today that work has begun under the collaborative agreement signed between the Company and several farming cooperatives in Quang Nam Province, Vietnam.  As part of the agreement reported earlier this month, these farming cooperatives have now begun planting mulberry.  This mulberry is the key input for the Company’s newly formed subsidiary, Prodigy Textiles, its proprietary hybrid silkworms, and the commercialization of the Company’s recombinant spider silk materials.

Silkworms are voracious eaters, consuming more than 100 kilograms of mulberry leaves for every kilogram of finished silk produced.  For this reason, transportation logistics and local sourcing of mulberry are core to the Company’s strategic plan.  Under these agreements the Company expects that as many as 2,500 hectares (~6177 acres) of mulberry will be planted near the Company’s new factory, supporting Prodigy Textiles spider silk production for several years to come.

“Planting these mulberry fields means that we now able to support rearing our hybrid silkworms at Prodigy Textiles,” said Jon Rice, COO.  “Access to large quantities of fresh mulberry is a core piece of our production growth strategy and was a key element of our decision to select Vietnam for commercializing our spider silk technology.  The local farming cooperatives have the existing capacity to meet Prodigy’s mulberry needs over the coming months.  These additional plantings provide us with the confidence that we will be able to maitain our scale up plans for years to come, while also providing these farmers with sustaining and reliable income.” 

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

 

This entry was posted on by .

Kraig Biocraft Laboratories accelerates its Spider Silk production ramp up, the result of recent meetings with Senior Vietnamese and US Embassy officials

ANN ARBOR, Mich., – July 24, 2018 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces today that Jon Rice, the Company’s COO, held meetings with senior Vietnamese officials, in Quang Nam, and US government officials, at the US Embassy, in Hanoi, Vietnam, to advance its production ramp-up plan for Prodigy Textiles Co., Ltd. 

The Company has already received its business license for Prodigy Textiles and its investment authorization for up to $2.2 million, to fund the first phase of its spider silk commercialization scale up efforts in Quang Nam.  This approved first phase includes the importation of the Company’s hybrid silkworms and production of Prodigy Textiles’ unique high performance silk.

During the meeting with officials in Quang Nam, the Company requested an acceleration of the project schedule, including authorization and the investment license for the second phase of operations, with a total investment cap of up to $50 million.  The second phase of the Company’s investment plan includes the development of a 50 hectare parcel of land and the construction of a new dedicated factory, designed to support the Company’s five year expected recombinant spider silk production output needs.  The Company has already begun to work with a local architectural firm to develop the plans for this unprecedented facility and spider silk production complex.

“Our meetings in Vietnam were highly productive. Working with officials in Quang Nam, our team of consultants, and US government staff in Hanoi, we have establish a clear plan and roadmap to accelerating our efforts to bring affordable spider silk to the global market,” stated Jon Rice, COO.  “The first phase of this effort is underway now and, based on our recent meeting, we hope to have authorization for the expanded phase two effort well ahead of our initial schedule.”

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

 

This entry was posted on by .

Kraig Biocraft Laboratories subsidiary Prodigy Textiles signs agreements for mulberry production

ANN ARBOR, Mich., – July 12, 2018 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers announces today that its subsidiary Prodigy Textiles has signed three agreements with local farming cooperatives in Quang Nam province, Vietnam.  Under these agreements the farmers will produce the mulberry necessary to support the Company’s recombinant spider silk production. 

This collaboration with local farmers is a key element of Kraig Labs commercialization strategy, integrating advancements in high tech agriculture and a diverse supply base with the Company’s ground breaking spider silk production technology.

 “The strength of our approach in creating cost effective and commerciality scalable spider silk has always been based on the use of the existing silk infrastructure,” said Jon Rice, COO.  “Today’s announcement, that we are developing collaborative relationships with these farming cooperatives, is a perfect example of that strategy put into action.  These efforts will provide us with sufficient mulberry to meet our production expansion plans for the next several years.  In the coming months we expect to expand this model of collaboration by incorporating efforts with downstream processors such as reeling and thread finishing.” 

Prodigy Textiles Co. Ltd., signed three memorandums of understanding with independent farming cooperatives at a signing ceremony held at its recently announced new facility in Quang Nam province. 

The Company wishes to offer special thanks to its team of consultants who have put in considerable effort to assist us on this endeavor.  Leading this project was Mr. Kenneth Le, whose dedication, resourcefulness, and business acumen has been instrumental in our ability to conduct business on the other side of the globe.  Mr. Le has played a critical role in supporting scaling up the Company’s spider silk technology beyond the laboratory and with eyes towards the global textile markets.

“Mr. Le has demonstrated an incredible dedication to advancing this technology,” said CEO and Founder Kim Thompson.  “He has been generous with his time while proving unmatched knowledge of international business and an ability to conduct business in Southeast Asia.  Beyond the Company’s appreciation, I would like to personally thank Ken for his sage advice, his honesty, and his guidance throughout this process.  Together, we continue to break new ground in the commercialization of spider silk.”

To view the most recent edition of Kraig’s Spider Sense newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

 

This entry was posted on by .

Kraig Biocraft Laboratories celebrates the opening of Prodigy Textiles Co. Ltd., facility in Quang Nam, Vietnam

ANN ARBOR, Mich., – July 10, 2018 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers announces that, during its trip to Vietnam last week, the Company celebrated the grand opening of Prodigy Textiles new facility in Quang Nam province.  This facility will have the capacity, utilities, and security to support the planned capacity growth in Vietnam through the first phase of operations and will be the launch pad for future expansion on a pre-designated 50 hectare parcel of land located nearby.

Working in partnership with its consultants in Vietnam, the Company reviewed numerous buildings and locations throughout the province.  The Company ultimately selecting this facility due to its proximity to mulberry production, building layout, condition, utilities, and its proximity to shipping ports and the Company’s planned 50 hectare future campus.

The opening celebration was attended by officials from the province and local district, as well as leaders from the farming cooperatives that will provide mulberry and senior banking officials.

“Having now seen the new facility first hand I am confident that we will soon have a thriving operation up and running,” said Jon Rice, COO.  “We are now in the process of getting the final building updates outlined and completed so that it will be ready to receive the first shipment of our silkworms.  Our team in Vietnam continues to put in an incredible amount of effort to bring this ground breaking project to reality.”

To view the most recent edition of Kraig’s Spider Sense newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

 

This entry was posted on by .

Kraig Biocraft Laboratories management travels to Vietnam to oversee the opening of its spider silk production subsidiary, Prodigy Textiles Co. Ltd.,

ANN ARBOR, Mich., – July 3, 2018 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers announces today that Jon Rice, the Company’s COO, is in Vietnam this week reviewing the new facility, interviewing potential hires, and meeting with local officials, as the next phase in launching operations at its newly formed production subsidiary, Prodigy Textiles Co. Ltd. 

This trip marks the first time that Company management will be on the ground in Vietnam, since receiving its investment and enterprise registration certificates, the essential business licenses the Company had worked diligently to secure.  Mr. Rice will remain in Vietnam through the end of the week, ensuring that the factory is on track to receive its first delivery of its proprietary hybrid silkworms.

“I am excited to see the new facility first hand and to review the progress getting the building ready to receive our hybrid silkworms,” said Rice.  “Our consultants on the ground have been doing an excellent job of keeping this project moving forward.  This will be a busy week of meetings, as we coordinate with contractors, officials, and potential new employees, as we work to get Prodigy Textiles up and running.”

The Company’s research team continues to prepare silkworm’s eggs for shipment, from its Michigan based R&D headquarters, and remains on track to ship materials, as soon as the new facility in Vietnam is ready.

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

 

This entry was posted on by .

Kraig Biocraft Laboratories works with local cooperative to expand Mulberry production in Quang Nam, Vietnam

Plans to add nearly 2,500 acres of mulberry to support commercialization scale of up of the Company’s recombinant spider silk technology

ANN ARBOR, Mich., – June 26, 2018 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers announces today that the Company’s representatives in Quang Nam province, Vietnam are working, in collaboration with a local cooperative, to expand mulberry production.   This effort is a major element of the Company’s production expansion plans and marks a significant increase in capacity. 

News of this collaboration was recently published in a leading Vietnamese digital media outlet, which highlights the efforts to focus on high technology agriculture and re-energize the Vietnamese share of the multi-billion dollar sericulture industry.  Expanding mulberry production in Quang Nam, by nearly 2,500 acres, is a powerful step to increasing total silk production and a key component of the Company’s plan to bring its spider silk technology to market.

“Collaboration with local farmers and workers, leveraging their expertise and knowledge, is core to our production scale up efforts,” said Jon Rice COO.  “This effort highlights the complementary efforts that we are taking, in combination with the leadership in Quang Nam, to restore their traditional sericulture industry, by blending in new high technology agriculture. This continued collaboration will play a key part in the exciting growth potential we’re seeing with our expansion in Vietnam and the market for affordable spider silk materials.”

Original Source Article

http://thoibaokinhdoanh.vn/hop-tac-xa/quang-nam-htx-lien-ket-voi-cong-ty-my-dau-tu-nganh-dau-tam-1048434.html

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

This entry was posted on by .

Kraig Biocraft Laboratories produces first roll of pure Dragon Silk fabric for U.S. Army

ANN ARBOR, Mich., – June 21, 2018 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers announces today that it has just finished the production of its first roll of pure Dragon Silk fabric, marking the first time that the Company’s proprietary recombinant spider silk fibers were used to create a 100% pure woven silk fabric.

The Company is now preparing to assemble the Dragon Silk material into finalized ballistic shoot packs, per the U.S. Army specifications.  This materials is destined for ballistic performance testing, under the Company’s contract with the U.S. Army, to evaluate its potential for protective apparel applications.

“Dragon Silk, which started as a simple idea in the lab for a better performing silk, is now on the verge of demonstrating its capability to provide lifesaving performance blended with high flexibility and user comfort,” said Jon Rice COO.  “What a proud moment for the Company and all of our employees, as we prepare to process this first roll of Dragon Silk fabric into test samples for the U.S. Army and to assess its ability to assist in protecting the brave men and women of our armed forces, who dedicate themselves to protecting all of us.”

The Company previously developed sample products, in pure and blended knit configurations using its Monster Silk materials, including shirts and gloves.  Today’s announcement marks the first time the Company’s newer and stronger Dragon Silk will be transitioned into an end product.

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

 

This entry was posted on by .

Kraig Biocraft Laboratories deploys new Spider Silk DNA synthesis methodology

More than 2,500 test microinjections completed with expanded lab staff to boost throughput

ANN ARBOR, Mich., – June 12, 2018 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers announces today that the Company has completed more than 2,500 microinjections using the recently announced new spider silk DNA synthesis methodology.  This new method allows for faster creation of larger and more complex spider silk proteins.  Larger and more complex proteins are believed to produce improved silk strength, toughness, and elasticity.  These improved recombinant spider silk fibers will allow the Company to target an expanded set of end market applications.

To support this expanded research and development capability, the Company added two laboratory staff for increased testing throughput.  The additional lab staff members have been trained and have conducted the majority of the microinjection effort.

By implementing this new validated protocol and completing these initial microinjections, the Company is looking forward to creating new transgenics, at Kraig Labs’ U.S. R&D headquarters, with an abridged development cycle and enhanced materials performance.  The transgenics created using the new protocols are expected to be transitioned into Prodigy Textiles’, the Company’s recently announced Vietnamese subsidiary, commercial production process.  

“Thanks to our lab and production teams’ considerable collaborative effort, this new methodology has already demonstrated the potential to significantly reduce our development timelines. To see it put into practice so quickly and to have already completed the first 2,500 test microinjections is very impressive,” said Jon Rice, COO.  “I look forward to seeing this capability enable the next generation of recombinant spider silk fibers.”

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

 

This entry was posted on by .